undamentalytics Newsletter

Curis Inc income statement

In fiscal 2025, Curis Inc reported revenue of $9.4m, down 13.4% on the year before, operating income of −$5.7m (a -60.5% margin) and net income of −$7.6m, or −$0.58 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Curis Inc: income statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue9161517151088101010111110101194
Research and development101114151314271845242223354339392825
General and administrative9108101112131614151212172019171415
Operating income−10−6−7−19−9−16−56−58−50−29−24−25−42−53−48−45−6−9
Interest expense———0443344100—————
Income tax———————————————00—
Net income−10−4−10−16−12−19−59−60−53−33−32−30−45−57−47−43−8−21
Diluted EPS−$0.04−$1.50−$3.25−$5.25−$3.75−$5.50−$12.00−$2.25−$8.95−$4.90−$4.85−$3.05$5.00−$6.07−$4.48−$3.44−$0.58—
Diluted shares (average)—3m3m3m3m3m5m5m6m7m7m10m9m9m11m13m13m—
EBITDA−9−5−7−18−9−16−56−58−50−29−24−25−42−53−48−44−6−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CAMP vs CRISCRIS vs ENSCCRIS vs OCGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Curis Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Curis Inc.